Total Payments
$608.14
2024 Payments
$24.77
Companies
6
Transactions
27
Medicare Patients
4,166
Medicare Billing
$440,256
Payment Breakdown by Category
Food & Beverage$434.89 (71.5%)
Gifts$173.25 (28.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $434.89 | 22 | 71.5% |
| Gift | $173.25 | 5 | 28.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $300.27 | 15 | $0 (2024) |
| Braintree Laboratories, Inc. | $173.25 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $55.95 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $31.73 | 2 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $29.16 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $17.78 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.77 | 1 | ABBVIE INC. ($24.77) |
| 2023 | $75.88 | 4 | Merck Sharp & Dohme LLC ($32.86) |
| 2022 | $378.10 | 17 | ABBVIE INC. ($214.42) |
| 2021 | $53.50 | 2 | Braintree Laboratories, Inc. ($40.23) |
| 2020 | $53.32 | 2 | Braintree Laboratories, Inc. ($53.32) |
| 2019 | $22.57 | 1 | AbbVie, Inc. ($22.57) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/08/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 02/02/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/23/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.74 | General |
| 11/22/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $29.16 | General |
| Category: GI | ||||||
| 11/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/17/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $39.85 | General |
| Category: GI COLON PREP | ||||||
| 07/19/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/12/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $39.85 | General |
| Category: GI COLON PREP | ||||||
| 02/17/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 10/11/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $40.23 | General |
| Category: GI COLON PREP | ||||||
| 09/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2020 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | Cash or cash equivalent | $26.66 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,029 | 1,210 | $408,793 | $112,581 |
| 2022 | 13 | 1,084 | 1,288 | $378,285 | $107,758 |
| 2021 | 14 | 1,077 | 1,309 | $389,205 | $116,069 |
| 2020 | 16 | 976 | 1,181 | $352,519 | $103,848 |
Total Patients
4,166
Total Services
4,988
Medicare Billing
$440,256
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 276 | 300 | $67,500 | $32,077 | 47.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 223 | 359 | $43,080 | $23,798 | 55.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 101 | $17,675 | $8,108 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 108 | $13,500 | $7,111 | 52.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $26,400 | $4,566 | 17.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 64 | 64 | $38,400 | $4,395 | 11.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 11 | 12 | $17,400 | $4,322 | 24.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $34,400 | $3,946 | 11.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 18 | 18 | $21,600 | $3,926 | 18.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $25,368 | $3,604 | 14.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 15 | 15 | $18,000 | $3,450 | 19.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 30 | 30 | $24,000 | $2,917 | 12.2% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 17 | 17 | $8,500 | $2,649 | 31.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $11,550 | $2,248 | 19.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Office | 2023 | 16 | 16 | $3,600 | $1,741 | 48.4% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 16 | 16 | $15,200 | $1,527 | 10.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 25 | 25 | $15,000 | $1,153 | 7.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,600 | $975.85 | 14.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 16 | 17 | $1,020 | $66.30 | 6.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 270 | 284 | $63,900 | $32,079 | 50.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 220 | 371 | $44,520 | $22,249 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 141 | $17,625 | $10,095 | 57.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 90 | 90 | $15,750 | $7,981 | 50.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 70 | 73 | $43,800 | $5,235 | 12.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 47 | 47 | $37,600 | $4,657 | 12.4% |
About Dr. Michael Mello, MD
Dr. Michael Mello, MD is a Gastroenterology healthcare provider based in Glendale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356571566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mello, MD has received a total of $608.14 in payments from pharmaceutical and medical device companies, with $24.77 received in 2024. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($434.89).
As a Medicare-enrolled provider, Mello has provided services to 4,166 Medicare beneficiaries, totaling 4,988 services with total Medicare billing of $440,256. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Glendale, CA
- Active Since 07/22/2009
- Last Updated 03/11/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1356571566
Products in Payments
- SUTAB (Drug) $119.93
- SKYRIZI (Biological) $78.36
- HUMIRA (Biological) $70.24
- CREON (Drug) $58.77
- DIFICID (Drug) $55.95
- SUPREP BOWEL PREP (Drug) $53.32
- RINVOQ (Biological) $43.84
- Linzess (Drug) $29.16
- LINZESS (Drug) $26.49
- STELARA (Biological) $17.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Glendale
Richard Manch, M.d, M.D
Gastroenterology — Payments: $630,233
Gastroenterology $630,233
Frederick Boghossian, M.d, M.D
Gastroenterology — Payments: $175,402
Gastroenterology $175,402
Armine Sarkisian, M.d, M.D
Gastroenterology — Payments: $124,705
Gastroenterology $124,705
Mr. James Tabibian, M.d, M.D
Gastroenterology — Payments: $39,283
Gastroenterology $39,283
Dr. Vikram Singh, M.d, M.D
Gastroenterology — Payments: $34,147
Gastroenterology $34,147
Dr. Rimma Shaposhnikov, M.d, M.D
Gastroenterology — Payments: $23,780
Gastroenterology $23,780